WAS and neoplasm: Oncogenes show specific activity in tumor cells (Fig. 5g, 5h), with LMO2, LYN, TNFRSF17, CARD11, and BCL7A being active in Tumor B1, while BCL2 and WAS are specifically active in Tumor B2.